Aratana Therapeutics (PETX) Tops Q4 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. DOX
3. BKNG
4. DUOL
5. SWKS
6. AMGN
7. ANET
8. XYZ
9. CVS
10. FISV

Go back to Aratana Therapeutics (PETX) Tops Q4 EPS by 4c

Aratana Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results

March 14, 2016 4:05 PM EDT

LEAWOOD, Kan., March 14, 2016 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, announced its fourth quarter 2015 and full year 2015 financial results. For the quarter ended December 31, 2015, Aratana reported a net loss of $12.9 million or $0.37 basic loss per share and for the full year of 2015, Aratana reported a net loss of $84.1 million or $2.45 basic loss per share.

"Aratana achieved significant progress on our late-stage product candidates during 2015. We anticipate our first FDA approval on... More